CytomX Therapeutics (CTMX) Amortizatization of Intangibles (2014 - 2026)

CytomX Therapeutics (CTMX) has 13 years of Amortizatization of Intangibles data on file, last reported at $726000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles rose 59.91% year-over-year to $726000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 36.45% YoY) and the FY2025 annual result came in at $2.2 million, down 58.46% from the prior year.
• Amortizatization of Intangibles grew to $726000.0 in Q1 2026, from $719000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $2.2 million in Q4 2023 to a low of $5000.0 in Q4 2022.
• A 5-year average of $924352.9 and a median of $726000.0 in 2026 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 44420.0% — and 2025, when it sank 75.67%.
• Tracing CTMX's Amortizatization of Intangibles over 5 years: stood at $5000.0 in 2022, then jumped by 44420.0% to $2.2 million in 2023, then slumped by 64.65% to $787000.0 in 2024, then slipped by 8.64% to $719000.0 in 2025, then grew by 0.97% to $726000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $726000.0 (Q1 2026), $719000.0 (Q4 2025), and $636000.0 (Q3 2025), per Business Quant data.